NTUC Learninghub Partners World Leading Online Learning Provider Go1 to Launch Over 100 Free Handpicked Courses During ‘Circuit Breaker’ Period

SINGAPORE - Media OutReach - 11 April 2020 - As the leading Continuing Education and Training provider in…

Uloo Lets You Work on Your Habits Together and Book Sessions with Mentors

Uloo GmbH built a revolutionary mobile app to change the way we work on our…

Shareholder Alert: Robbins LLP Reminds Investors Luckin Coffee Inc. (LK) Sued for Misleading Shareholders

SAN DIEGO & XIAMEN, China--(BUSINESS WIRE)--$LK #ClassAction--Shareholder rights law firm Robbins LLP reminds investors that…

Cooper Tire to Restart Mexico Facility April 13; U.S. Plants to Remain Temporarily Closed

FINDLAY, Ohio--(BUSINESS WIRE)--Cooper Tire & Rubber Company (NYSE: CTB) today announced it plans to restart…

MEDICREA Reports 2019 Annual Results and 2020 First Quarter Sales

Update on the Consequences on the Activity of the COVID-19 Pandemic LYON, France & NEW…

Silent Breach to Offer Free Vulnerability Assessments to Healthcare Providers

Esch-sur-Alzette, Luxembourg, April 10, 2020 --(PR.com)-- Silent Breach to begin offering free cybersecurity vulnerability assessments…

IQIYI INC (IQ) DROPS ON WOLFPACK REPORT: Labaton Sucharow Announces New Investigation of iQiyi and Strongly Encourages Investors with Losses to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Labaton Sucharow LLP, a nationally ranked and award winning investor rights law firm,…

Genetron Health Appoints Former FDA Senior Officer Dr. Yun-Fu Hu as Chief Medical Officer

BEIJING--(BUSINESS WIRE)--Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company, today announced the appointment…

NTT Solmare: Pre-registration Has Begun for the Newest Title from the “Moe! Ninja Girls” Series: “Moe! Ninja Girls RPG”

Pre-register Now and Get Amazing Items Upon Release! OSAKA, Japan--(BUSINESS WIRE)--#NTTsolmare--NTT Solmare Co., Ltd. (HQ:…

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-ENaC for Treatment of Cystic Fibrosis

PASADENA, Calif.--(BUSINESS WIRE)--$arwr--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application…